39062126|t|Ketosis Suppression and Ageing (KetoSAge) Part 2: The Effect of Suppressing Ketosis on Biomarkers Associated with Ageing, HOMA-IR, Leptin, Osteocalcin, and GLP-1, in Healthy Females.
39062126|a|Metabolic dysfunctions are among the best documented hallmarks of ageing. Cardiovascular disease, Alzheimer's disease, cancer, type 2 diabetes mellitus, metabolic-dysfunction-associated steatosis liver disease, and fragility fractures are diseases of hyperinsulinaemia that reduce life and healthspan. We studied the effect of suppressing ketosis in 10 lean (BMI 20.5 kg/m2 +- 1.4), metabolically healthy, pre-menopausal women (age 32.3 +- 8.9 years) maintaining nutritional ketosis (NK) for an average of 3.9 years (+- 2.3) who underwent three 21-day phases: nutritional ketosis (NK; P1), suppressed ketosis (SuK; P2), and returned to NK (P3). Ketosis suppression significantly increased insulin, 1.83-fold (p = 0.0006); glucose, 1.17-fold (p = 0.0088); homeostasis model assessment for insulin resistance (HOMA-IR), 2.13-fold (p = 0.0008); leptin, 3.35-fold (p = 0.0010); total osteocalcin, 1.63-fold (p = 0.0138); and uncarboxylated osteocalcin, 1.98-fold (p = 0.0417) and significantly decreased beta-hydroxybutyrate, 13.50-fold (p = 0.0012) and glucagon-like peptide-1 (GLP-1), 2.40-fold (p = 0.0209). Sustained NK showed no adverse health effects and may mitigate hyperinsulinemia. All biomarkers returned to basal P1 levels after removing the intervention for SuK, indicating that metabolic flexibility was maintained with long-term euketonaemia.
39062126	0	7	Ketosis	Disease	MESH:D007662
39062126	76	83	Ketosis	Disease	MESH:D007662
39062126	131	137	Leptin	Gene	3952
39062126	139	150	Osteocalcin	Gene	632
39062126	156	161	GLP-1	Gene	2641
39062126	183	205	Metabolic dysfunctions	Disease	MESH:D008659
39062126	257	279	Cardiovascular disease	Disease	MESH:D002318
39062126	281	300	Alzheimer's disease	Disease	MESH:D000544
39062126	302	308	cancer	Disease	MESH:D009369
39062126	310	334	type 2 diabetes mellitus	Disease	MESH:D003924
39062126	336	357	metabolic-dysfunction	Disease	MESH:D008659
39062126	369	378	steatosis	Disease	MESH:D005234
39062126	379	392	liver disease	Disease	MESH:D008107
39062126	398	417	fragility fractures	Disease	MESH:D005600
39062126	434	451	hyperinsulinaemia	Disease	
39062126	522	529	ketosis	Disease	MESH:D007662
39062126	604	609	women	Species	9606
39062126	646	665	nutritional ketosis	Disease	MESH:D007662
39062126	667	669	NK	Disease	MESH:D007662
39062126	743	762	nutritional ketosis	Disease	MESH:D007662
39062126	764	766	NK	Disease	MESH:D007662
39062126	784	791	ketosis	Disease	MESH:D007662
39062126	793	796	SuK	Disease	MESH:D007662
39062126	819	821	NK	Disease	MESH:D007662
39062126	828	835	Ketosis	Disease	MESH:D007662
39062126	872	879	insulin	Gene	3630
39062126	905	912	glucose	Chemical	MESH:D005947
39062126	971	989	insulin resistance	Disease	MESH:D007333
39062126	1025	1031	leptin	Gene	3952
39062126	1063	1074	osteocalcin	Gene	632
39062126	1119	1130	osteocalcin	Gene	632
39062126	1183	1203	beta-hydroxybutyrate	Chemical	MESH:D020155
39062126	1233	1256	glucagon-like peptide-1	Gene	2641
39062126	1258	1263	GLP-1	Gene	2641
39062126	1300	1302	NK	Disease	MESH:D007662
39062126	1353	1369	hyperinsulinemia	Disease	MESH:D006946
39062126	1450	1453	SuK	Disease	MESH:D007662
39062126	1523	1535	euketonaemia	Disease	
39062126	Association	MESH:D007662	3952
39062126	Association	MESH:D020155	MESH:D007662
39062126	Association	MESH:D007662	3630
39062126	Association	MESH:D005947	MESH:D007662
39062126	Association	MESH:D007662	632

